Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(12):e49894.
doi: 10.1371/journal.pone.0049894. Epub 2012 Dec 12.

Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings

Fiona J McCann  1 , Stephen J Chapman, Wai Cho Yu, Nick A Maskell, Robert J O Davies, Y C Gary Lee
Affiliations

Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings

Fiona J McCann et al. PLoS One. 2012.

Abstract

Procalcitonin has been shown to be useful in separating infection from non-infective disorders. However, infection is often paralleled by tissue inflammation. Most studies supporting the use of procalcitonin were confounded by more significant inflammation in the infection group. Few studies have examined the usefulness of procalcitonin when adjusted for inflammation.Pleural inflammation underlies the development of most exudative effusions including pleural infection and malignancy. Pleurodesis, often used to treat effusions, involves provocation of intense aseptic pleural inflammation. We conducted a two-part proof-of-concept study to test the specificity of procalcitonin in differentiating infection using cohorts of patients with pleural effusions of infective and non-infective etiologies, as well as subjects undergoing pleurodesis.

Methods: We measured the blood procalcitonin level (i) in 248 patients with pleural infection or with non-infective pleural inflammation, matched for severity of systemic inflammation by C-reactive protein (CRP), age and gender; and (ii) in patients before and 24-48 hours after induction of non-infective pleural inflammation (from talc pleurodesis).

Results: 1) Procalcitonin was significantly higher in patients with pleural infection compared with controls with non-infective effusions (n = 32 each group) that were case-matched for systemic inflammation as measured by CRP [median (25-75%IQR): 0.58 (0.35-1.50) vs 0.34 (0.31-0.42) µg/L respectively, p = 0.003]. 2) Talc pleurodesis provoked intense systemic inflammation, and raised serum CRP by 360% over baseline. However procalcitonin remained relatively unaffected (21% rise). 3) Procalcitonin and CRP levels did not correlate. In 214 patients with pleural infection, procalcitonin levels did not predict the survival or need for surgical intervention.

Conclusion: Using a pleural model, this proof-of-principle study confirmed that procalcitonin is a biomarker specific for infection and is not affected by non-infective inflammation. Procalcitonin is superior to CRP in distinguishing infection from non-infective pleural diseases, even when controlled for the level of systemic inflammation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. In two groups of patients matched for CRP levels, procalcitonin levels in blood were significantly higher in patients with pleural infection than in those with non-infectious (malignant) pleural effusion.
* One outlier in the non-infective group lay outside the margins of the graph and was not shown. (Measurement of procalcitonin in two samples failed and were excluded resulting in a final number of n = 30 in each group; Wilcoxon Signed Rank test).
Figure 2
Figure 2. Changes in Procalcitonin and CRP before and after a non-infectious pro-inflammatory stimulus (talc pleurodesis).
* The PCT values of three outliers (1 pre- and 2 post-pleurodesis) lied outside the margins of the graph and were not shown. N = 32 in each group (Wilcoxon Signed Rank test).
Figure 3
Figure 3. Procalcitonin levels were not significantly different between patients with favorable or poor outcomes matched for age, gender and CRP.
N = 97 in each group; Wilcoxon Signed Rank test.
Figure 4
Figure 4. Procalcitonin and CRP levels between empyema patients with purulent (n = 41) and non-purulent pleural effusions (n = 174);
Mann Whitney Ranked Sum test.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schuetz P, Amin DN, Greenwald JL (2012) Role of procalcitonin in managing adult patients with respiratory tract infections. Chest 141: 1063–73. - PubMed
    1. Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36: 941–52. - PubMed
    1. Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, et al. (1999) Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med 37: 789–97. - PubMed
    1. Olah A, Belágyi T, Issekutz A, Makay R, Zaborszky A (2005) Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis. Hepatogastroenterology 52: 243–5. - PubMed
    1. Brunkhorst FM, Eberhard OK, Brunkhorst R (1999) Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 27: 2172–6. - PubMed

Publication types